Clinical trials: Exenatide provides benefit in Parkinson's disease

Charlotte, Harrison
July 2013
Nature Reviews Drug Discovery;Jul2013, Vol. 12 Issue 7, p506
Academic Journal
The article discusses research being done on the efficacy of exenatide in patients with moderate Parkinson's disease, referencing a study by I. Aviles-Olmos et al published in a 2013 issue of the "Journal of Clinical Investigation."


Related Articles

  • Improved control of brittle Parkinsonism by separate administration of levodopa and benserazide. McLean, D.L.; Dean, B.C. // British Medical Journal (Clinical Research Edition);4/3/1982, Vol. 284 Issue 6321, p1001 

    Examines the efficacy of the separate administration of levodopa and benserazide for the control of brittle Parkinsonism. Deterioration of the control through the state of severe Parkinsonism to a state of incapacitating chorea; Method for re-establishing the control; Effect of food intake to...

  • Alternatives to levodopa.  // British Medical Journal;5/15/1976, Vol. 1 Issue 6019, p1169 

    Focuses on the efficacy of levodopa for treating Parkinson's disease in Great Britain. Response of the patients to the treatment; Impact of the severe depletion of striatal dopa decarboxylase on the therapeutic effect of levodopa; Usefulness of dopamine agonists in conditions associated with...

  • Selegiline in the treatment of early Parkinson's disease.  // American Family Physician;4/1/1996, Vol. 53 Issue 5, p1866 

    Focuses on the effectiveness of the combination of levodopa and selegiline in the treatment of patients with early mild Parkinson's disease. Methodology of study; Number of participants; Mortality of patients; Author's conclusions; Study from A.J. Lees of BMJ 1995.

  • RESEARCH ROUNDUP. Storey, Stacey // British Journal of Neuroscience Nursing;Aug/Sep2013, Vol. 9 Issue 4, p204 

    The article offers updates related to research studies in neuroscience nurses. A clinical trial reveal that exenatide might have true promise in helping to slow down Parkinson's in some people. New research indicates that people who eat peppers might have lessened risk of developing Parkinson's...

  • Injection-free exenatide well tolerated, effective at higher doses. Costa, Samantha; Fisher, Stacey L.; Foster, Melissa // Endocrine Today;Nov2012, Vol. 10 Issue 11, p27 

    The article reports on a study which found that higher doses of injection-free exenatide were well-tolerated and reduced HbA1c levels in patients with type 2 diabetes.

  • Exenatide.  // Reactions Weekly;1/26/2013, Issue 1436, p17 

    The article describes the case of a 58-year-old man who developed acute tubulointerstitial nephritis while undergoing exenatide therapy for type 2 diabetes mellitus.

  • Liraglutide beats exenatide in diabetes-related pharmacy costs.  // PharmacoEconomics & Outcomes News;Feb2014, Vol. 696 Issue 1, p5 

    The article looks at the study "Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide" in the January 30, 2014 issue of "Advances in Therapy" which focused on diabetes-related pharmacy costs in using liraglutide and exenatide.

  • Exenatide.  // Reactions Weekly;May2015, Vol. 1553 Issue 1, p145 

    The article presents a case study of a 52-year-old diabetic man who developed systemic hypersensitivity and nausea during treatment with exenatide.

  • Continuing Education Case Study Quiz.  // Hospital Pharmacy;Aug2012, Vol. 47 Issue 8, p645 

    The article presents a continuing education quiz designed to educate pharmacists on the use of exenatide extended-release (ER) in patients with type 2 diabetes mellitus, and includes questions such as the use of exenatide ER injection as first-line therapy, its administration, and its...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics